Analyst Upgrades: Tesla Motors, Monsanto, AbbVie

Analysts upwardly revised their ratings and price targets on Tesla Motors Inc (NASDAQ:TSLA), Monsanto Company (NYSE:MON), and AbbVie Inc (NYSE:ABBV)

Jun 8, 2015 at 10:01 AM
facebook X logo linkedin

Analysts are weighing in today on electric automaker Tesla Motors Inc (NASDAQ:TSLA), agricultural concern Monsanto Company (NYSE:MON), and biopharmaceutical firm AbbVie Inc (NYSE:ABBV). Here's a quick roundup of today's bullish brokerage notes on TSLA, MON, and ABBV.

  • TSLA is up 2.6% this morning at $255.70 on reports Panasonic is sending hundreds of employees to the car producer's Gigafactory in Nevada to prepare to make lithium-ion batteries next year. On top of this, Baird raised its price target to $335 from $275, marking a 31% premium to current levels. The shares have been solid on the charts, adding 15% in 2015. Option traders have been betting on more upside, too. Tesla Motors Inc's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio of 1.35 is higher than three-fourths of comparable readings from the past year. On a separate note, TSLA will hold its annual shareholder meeting tomorrow.

  • MON's second takeover bid for Syngenta AG (ADR) (NYSE:SYT) has been rejected, with the latter company citing regulatory concerns. Regardless, Monsanto Company is up 0.6% on the day at $114.62, as it received an upgrade at Atlantic Equities to "neutral" from "underweight." Analysts are split on the stock. While seven brokerage firms say it's a "strong buy," six others deem it only a "hold." Going by its recent price action, the bearish attention seems more deserving. MON has dropped 9% since touching a 2015 high of $126 on Feb. 25.

  • Thanks to a pair of price-target hikes, ABBV has added 0.6% this morning to hit $67.90. Specifically, Jefferies upped its price target to $90 from $86, while Credit Suisse raised its mark to $72 from $69. The Street already has a decidedly bullish stance on the shares, with 80% of brokerage firms calling them a "strong buy," and not a single "sell" to be found. On the charts, AbbVie Inc has been gaining lately, outpacing the S&P 500 Index (SPX) by almost 15 percentage points over the past three months. 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI